Literature DB >> 16247073

Results of intervention for lupus patients with self-perceived cognitive difficulties.

M J Harrison1, K A Morris, R Horton, J Toglia, J Barsky, S Chait, L Ravdin, L Robbins.   

Abstract

The authors developed an 8-week psychoeducational group intervention for patients with systemic lupus erythematosus (SLE) who reported cognitive dysfunction but were not globally impaired on neuropsychological testing. Results of a nonrandomized, uncontrolled pilot study of this program in 17 women with SLE suggest that metamemory and memory self-efficacy improve after participation. One hundred percent retention throughout the study further suggests that patients with SLE are willing and capable of successfully completing the program.

Entities:  

Mesh:

Year:  2005        PMID: 16247073     DOI: 10.1212/01.wnl.0000180938.69146.5e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.

Authors:  Tricia S Williams; Cynthia Aranow; Gail S Ross; Alexandra Barsdorf; Lisa F Imundo; Andrew H Eichenfield; Philip J Kahn; Betty Diamond; Deborah M Levy
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

2.  SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus.

Authors:  J G Hanly; M B Urowitz; D Jackson; S C Bae; C Gordon; D J Wallace; A Clarke; S Bernatsky; A Vasudevan; D Isenberg; A Rahman; J Sanchez-Guerrero; J Romero-Diaz; J T Merrill; P R Fortin; D D Gladman; I N Bruce; K Steinsson; M Khamashta; G S Alarcón; B Fessler; M Petri; S Manzi; O Nived; G Sturfelt; R Ramsey-Goldman; M A Dooley; C Aranow; R Van Vollenhoven; M Ramos-Casals; A Zoma; K Kalunian; V Farewell
Journal:  Ann Rheum Dis       Date:  2011-02-21       Impact factor: 19.103

Review 3.  Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment.

Authors:  Melanie J Harrison; Lisa D Ravdin
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 4.  Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.

Authors:  Carol M Greco; Claire Nakajima; Susan Manzi
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 5.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

Review 6.  Diagnosis and management of neuropsychiatric SLE.

Authors:  John G Hanly
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

Review 7.  New insights into central nervous system lupus: a clinical perspective.

Authors:  John G Hanly
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

Review 8.  Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management.

Authors:  Dominic Seet; Nur Azizah Allameen; Jiacai Cho; Anselm Mak; Sen Hee Tay
Journal:  Rheumatol Ther       Date:  2021-05-15

9.  The Systemic Lupus Erythematosus Interventional Trials in Mainland China: A Continuous Challenge.

Authors:  Jingru Tian; Hang Zhou; Juan Liu; Feng Xiong; Ping Yi; Pengpeng Cao; Dorthy Fang; Bo Zhang; Qianjin Lu
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

10.  Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life.

Authors:  Moon Young Kim; Deepali Sen; Ronald R Drummond; Matthew C Brandenburg; Kathryn Lp Biesanz; Alfred Hj Kim; Seth A Eisen; Carolyn M Baum; Erin R Foster
Journal:  Lupus       Date:  2021-04-01       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.